Lab website: www.yuchilab.com

Tianjin University professor, tutor of doctor postgraduate, national outstanding youth. He received his A.B. from Fudan University, and Ph. D. from McMaster University, Canada. He was a postdoctoral fellow at Cold Spring Harbor Laboratory, New York, and moved back to Canada to work as a research associate at University of British Columbia. In 2016, he joined School of Pharmaceutical Science and Technology of Tianjin University. He focuses on the structural and functional studies of ion channel target proteins, as well as related disease mechanisms and high-throughput drug screening and development. So far, Mr. Yuchi has published more than eighty papers in international mainstream journals such as Nature, Nature Chemical Biology, Nature Communications, Molecular Cell, PNAS, eLife, JACS, ACS Catalysis, BMC Biology, etc, and applied for multiple patents. He served as the principal investigator for several national projects, including the National Key Research and Development Program of China and National Science Fund for Excellent Young Scholars. He is a member of Federation of the Asian and Oceanian Physiological Societies, Chinese Chemical Society, BSC Section of Ca²⁺ Signaling and China Anti-Cancer Association Section of Tumor Vaccine, etc., an editorial board member of Cancer Biology & Medicine, Current Pharmaceutical Design and Advanced Agrochem, etc. a guest reviewer of Nature Chemical Biology, Nature Communications, eLife and ACS Catalysis, etc. He has received the SinoChem Yangnong Agrochemical Innovation Award, Michael John Page Award, Michael Smith Award, and the ACS American Chemical Society Outstanding Faculty Advisor Award.